Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label aripiprazole in pediatric schizophrenia (extension of 031-09-003)
jRCT2080221113Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Long-term safety of aripiprazole.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080221113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221113.